| BNO S&P DJI Announces March 2019 Quarterly Rebalance |
| 08/03/19 | PRICE SENSITIVE | | Share |
|
| BNO Further Analysis of Phase 2 PTSD Trial Results Presentation |
| 18/02/19 | PRICE SENSITIVE | | Share |
|
| BNO Further Analysis of Phase 2 PTSD Results |
| 18/02/19 | PRICE SENSITIVE | | Share |
|
| BNO Half Yearly Report and Accounts |
| 15/02/19 | PRICE SENSITIVE | | Share |
|
| BNO Appendix 4C - quarterly |
| 31/01/19 | PRICE SENSITIVE | | Share |
|
| BNO BNC105 Clinical Trial In Combination With Nivolumab |
| 04/01/19 | PRICE SENSITIVE | | Share |
|
| BNO Bionomics Receives $650k Licensing Revenue from CTx |
| 21/12/18 | PRICE SENSITIVE | | Share |
|
| BNO Bionomics Receives Over $6.5m R&D Tax Incentive Refund |
| 11/12/18 | PRICE SENSITIVE | | Share |
|
| BNO CEO 2018 AGM Presentation |
| 14/11/18 | PRICE SENSITIVE | | Share |
|
| BNO Executive Chairman 2018 AGM Presentation |
| 14/11/18 | PRICE SENSITIVE | | Share |
|
| BNO FUND RAISING UPDATE |
| 14/11/18 | PRICE SENSITIVE | | Share |
|
| BNO Trading Halt |
| 12/11/18 | PRICE SENSITIVE | | Share |
|
| BNO Recapitalisation by major US-based biotechnology investor |
| 09/11/18 | PRICE SENSITIVE | | Share |
|
| BNO Leadership Changes and Strategic Review |
| 09/11/18 | PRICE SENSITIVE | | Share |
|
| BNO Appendix 4C - quarterly |
| 29/10/18 | PRICE SENSITIVE | | Share |
|
| BNO Bionomics' PTSD Trail Results Presentation |
| 02/10/18 | PRICE SENSITIVE | | Share |
|
| BNO Bionomics' PTSD Trial Results |
| 02/10/18 | PRICE SENSITIVE | | Share |
|
| BNO Trading Halt |
| 28/09/18 | PRICE SENSITIVE | | Share |
|
| BNO Bionomics 2017/2018 Preliminary Final Results |
| 16/08/18 | PRICE SENSITIVE | | Share |
|
| BNO Appendix 4C - quarterly |
| 20/07/18 | PRICE SENSITIVE | 258.5KB | Share |
|
| BNO End-of-Treatment Milestone Met in Phase 2 PTSD Trial |
| 09/07/18 | PRICE SENSITIVE | 110.08KB | Share |
|
| BNO Commencement of BNC210 Phase 2 Agitation Trial |
| 23/05/18 | PRICE SENSITIVE | 115.67KB | Share |
|
| BNO Appendix 4C - quarterly |
| 30/04/18 | PRICE SENSITIVE | | Share |
|
| BNO Bionomics Presents BNC101 and BNC105 Data at AACR Conference |
| 13/04/18 | PRICE SENSITIVE | | Share |
|
| BNO Half Yearly Report and Accounts |
| 14/02/18 | PRICE SENSITIVE | | Share |
|
| BNO Appendix 4C - quarterly |
| 31/01/18 | PRICE SENSITIVE | | Share |
|
| BNO Bionomics Receives Over $6.7m R&D Tax Incentive Refund |
| 16/01/18 | PRICE SENSITIVE | | Share |
|
| BNO Appendix 4C - quarterly |
| 31/10/17 | PRICE SENSITIVE | | Share |
|
| BNO BNC101 Phase 1 Clinical Trial Recruitment Completed |
| 31/10/17 | PRICE SENSITIVE | | Share |
|
| BNO Bionomics 2016/2017 Preliminary Final Results |
| 16/08/17 | PRICE SENSITIVE | | Share |
|
| BNO Appendix 4C - quarterly |
| 27/07/17 | PRICE SENSITIVE | | Share |
|
| BNO Bionomics Corporate Presentation May 2017 |
| 31/05/17 | PRICE SENSITIVE | | Share |
|
| BNO BNC210 Clinical Data Presented at US Psychiatry Convention |
| 18/05/17 | PRICE SENSITIVE | | Share |
|
| BNO Appendix 4C - quarterly |
| 26/04/17 | PRICE SENSITIVE | | Share |
|
| BNO New BNC105 Clinical Trial in Combination with Keytruda |
| 20/02/17 | PRICE SENSITIVE | | Share |
|
| BNO Half Yearly Report and Accounts |
| 17/02/17 | PRICE SENSITIVE | | Share |
|
| BNO MSD Cognition Program Milestone Payment |
| 03/02/17 | PRICE SENSITIVE | | Share |
|
| BNO Appendix 4C - quarterly |
| 31/01/17 | PRICE SENSITIVE | | Share |
|
| BNO CEO & Managing Director's Report to Shareholders |
| 08/11/16 | PRICE SENSITIVE | | Share |
|
| BNO Appendix 4C - quarterly-BNO.AX |
| 31/10/16 | PRICE SENSITIVE | | Share |
|
| BNO Positive BNC210 Phase 2 Anxiety Trial Results-BNO.AX |
| 21/09/16 | PRICE SENSITIVE | | Share |
|
| BNO Trading Halt-BNO.AX |
| 19/09/16 | PRICE SENSITIVE | | Share |
|
| BNO BNC210 Data to be Presented at ECNP-BNO.AX |
| 16/09/16 | PRICE SENSITIVE | | Share |
|
| BNO Bionomics 2015/2016 Preliminary Final Results-BNO.AX |
| 09/08/16 | PRICE SENSITIVE | | Share |
|
| BNO Appendix 4C - quarterly-BNO.AX |
| 29/07/16 | PRICE SENSITIVE | | Share |
|
| BNO BNO To Trial Drug Against Post-Traumatic Stress Disorder-BNO.AX |
| 30/06/16 | PRICE SENSITIVE | | Share |
|
| BNO Enrolment Completed in Generalised Anxiety Disorder Trial-BNO.AX |
| 24/06/16 | PRICE SENSITIVE | | Share |
|
| BNO Enrolment Completed in Generalised Anxiety Disorder Trial-BNO.AX |
| 24/06/16 | PRICE SENSITIVE | | Share |
|
| BNO Bionomics Receives Share of Funds from CTx License Deal-BNO.AX |
| 23/06/16 | PRICE SENSITIVE | | Share |
|
| BNO Appendix 4C - quarterly-BNO.AX |
| 29/04/16 | PRICE SENSITIVE | | Share |
|
| BNO BNC105 Cancer Immune Activation Data Presented at AACR-BNO.AX |
| 20/04/16 | PRICE SENSITIVE | | Share |
|
| BNO Bionomics Initiates Phase 1 Study of BNC101-BNO.AX |
| 04/04/16 | PRICE SENSITIVE | | Share |
|
| BNO Half Yearly Report and Accounts |
| 18/02/16 | PRICE SENSITIVE | | Share |
|
| BNO Appendix 4C - quarterly |
| 29/01/16 | PRICE SENSITIVE | | Share |
|
| BNO BNC210 Post Traumatic Stress Disorder Trial & Capital Raise |
| 08/12/15 | PRICE SENSITIVE | | Share |
|
| BNO Trading Halt |
| 04/12/15 | PRICE SENSITIVE | | Share |
|
| BNO NEW BNC105 DATA TO BE PRESENTED IN U.S. |
| 04/11/15 | PRICE SENSITIVE | | Share |
|
| BNO Appendix 4C - quarterly |
| 30/10/15 | PRICE SENSITIVE | | Share |
|
| BNO Merck Investment and Pain Partnership Extended |
| 08/10/15 | PRICE SENSITIVE | | Share |
|
| BNO BNO Reports Positive Data From BNC210 Clinical Trial |
| 16/09/15 | PRICE SENSITIVE | | Share |
|
| BNO BNC101 FDA SUBMISSION SUCCESSFUL |
| 31/08/15 | PRICE SENSITIVE | | Share |
|
| BNO Bionomics 2014/2015 Preliminary Final Results |
| 10/08/15 | PRICE SENSITIVE | | Share |
|
| BNO Appendix 4C - quarterly |
| 31/07/15 | PRICE SENSITIVE | | Share |
|
| BNO BNC105 Enhances Efficacy of Immuno-Oncology Therapies |
| 15/06/15 | PRICE SENSITIVE | | Share |
|
| BNO Appendix 4C - quarterly |
| 30/04/15 | PRICE SENSITIVE | | Share |
|
| BNO Bionomics Initiates Phase II BNC210 Clinical Trial |
| 20/04/15 | PRICE SENSITIVE | | Share |
|
| BNO BNC105 NEW DATA |
| 27/02/15 | PRICE SENSITIVE | | Share |
|
| BNO Half Yearly Report and Accounts |
| 23/02/15 | PRICE SENSITIVE | | Share |
|
| BNO Bionomics Begins Phase 1B Study With Anxiety Drug BNC210 |
| 02/02/15 | PRICE SENSITIVE | | Share |
|
| BNO Appendix 4C - quarterly |
| 30/01/15 | PRICE SENSITIVE | | Share |
|
| BNO Bionomics To Progress BNC210 In Clinical Trials |
| 11/11/14 | PRICE SENSITIVE | | Share |
|
| BNO Appendix 4C - quarterly |
| 31/10/14 | PRICE SENSITIVE | | Share |
|
| BNO BNC105 Data In International Peer-Reviewed Cancer Journal |
| 14/10/14 | PRICE SENSITIVE | | Share |
|
| BNO BNO Presents BNC105 Phase II Trial Biomarker Data |
| 29/09/14 | PRICE SENSITIVE | | Share |
|
| BNO Bionomics Acquires Prestwick Chemical |
| 23/09/14 | PRICE SENSITIVE | | Share |
|
| BNO Bionomics Receives $7.5M 2014 R&D Tax Incentive |
| 05/09/14 | PRICE SENSITIVE | | Share |
|
| BNO Bionomics 2013/2014 Preliminary Final Results |
| 19/08/14 | PRICE SENSITIVE | | Share |
|
| BNO Appendix 4C - quarterly |
| 31/07/14 | PRICE SENSITIVE | | Share |
|
| BNO Bionomics and Merck Enter New Research Collaboration |
| 24/06/14 | PRICE SENSITIVE | | Share |
|
| BNO Trading Halt |
| 23/06/14 | PRICE SENSITIVE | | Share |
|
| BNOAppendix 4C - quarterly |
| 30/04/14 | PRICE SENSITIVE | | Share |
|
| BNOBNC105 Phase II Renal Cancer Trial Results |
| 19/03/14 | PRICE SENSITIVE | | Share |
|
| BNOTrading Halt |
| 17/03/14 | PRICE SENSITIVE | | Share |
|
| BNOBionomics Partner Granted Further $34M in Funding |
| 24/02/14 | PRICE SENSITIVE | | Share |
|
| BNOHalf Yearly Report and Accounts |
| 18/02/14 | PRICE SENSITIVE | | Share |
|
| BNOBNC105 Achieves High Response Rate in Ovarian Cancer |
| 03/02/14 | PRICE SENSITIVE | | Share |
|
| BNOAppendix 4C - quarterly |
| 31/01/14 | PRICE SENSITIVE | | Share |
|
| BNOBionomics Receives $7.04M 2013 R&D Tax Incentive |
| 18/12/13 | PRICE SENSITIVE | | Share |
|
| BNOAppendix 4C - quarterly |
| 31/10/13 | PRICE SENSITIVE | | Share |
|
| BNOBionomics R&D Tax Incentive For FY2013 |
| 08/10/13 | PRICE SENSITIVE | | Share |
|
| BNOBionomics 2012/2013 Preliminary Final Results |
| 15/08/13 | PRICE SENSITIVE | | Share |
|
| BNOBionomics Signs Option and License Agreement with Merck |
| 31/07/13 | PRICE SENSITIVE | | Share |
|
| BNOAppendix 4C - quarterly |
| 30/07/13 | PRICE SENSITIVE | | Share |
|
| BNOBionomics initiates IND-enabling studies with BNC101 |
| 29/07/13 | PRICE SENSITIVE | | Share |
|
| BNOBNO completes enrolment in Phase II renal cancer trial |
| 11/06/13 | PRICE SENSITIVE | | Share |
|
| BNOBNC105 Trials Presented at ASCO |
| 03/06/13 | PRICE SENSITIVE | | Share |
|
| BNOCTX AND BIONOMICS' PROGRAM REACHES KEY MILESTONE |
| 16/05/13 | PRICE SENSITIVE | | Share |
|
| BNOAppendix 4C - quarterly |
| 30/04/13 | PRICE SENSITIVE | | Share |
|
| BNOManufacture of BNC101 commences at Lonza |
| 23/04/13 | PRICE SENSITIVE | | Share |
|
| BNOUnderwritten Rights Issue Offer Booklet |
| 04/03/13 | PRICE SENSITIVE | | Share |
|
